Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired 17 shares of common stock through a deferral plan, while also holding 98 shares indirectly through a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, acquired 17 shares of common stock on December 18, 2023, at a price of $579.76 per share.
• These shares were acquired as part of the Lilly Directors' Deferral Plan, where stock units are granted in lieu of cash compensation and will be settled in shares after her separation from service.
• Additionally, Ms. Hedley indirectly owns 98 shares of Eli Lilly common stock through a trust.
• Ms. Hedley disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director stock ownership and deferral plans are common across the pharmaceutical industry.
• Many companies, such as Pfizer (PFE) and Johnson & Johnson (JNJ), have similar programs for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

Eli Lilly, Director, Stock Acquisition, Deferral Plan, Beneficial Ownership, LLY